Abstract
Detection of minimal residual disease (MRD) in patients with B-cell acute lymphoblastic leukemia (B-ALL) has been achieved using several radioactive labelling methodologies; however, limited information exists about the use of chemiluminescent labelling. Although many malignant disorders are related to cytogenetic alterations, there is not a consistent chromosomal translocation that could serve as a tumour marker for the monitoring of MRD. ALL are derived from B-lymphocytes in 80% of cases. In the early stages of their maturation, the immunoglobulin heavy chain genes (IgH) undergo rearrangements among their V, D, and J segments, giving rise to the Complementary Determining Regions (CDR). Among these, CDR3 is considered unique for each lymphocyte and used as a tumour-specific marker in B-ALL patients. In this study, the CDR3 was labelled with digoxigenin and used as a patient-specific probe to test its sensitivity for further detection of MRD. Fourteen pretreatment samples of bone marrow (BM) or peripheral blood (PB) from B-ALL patients were included. Tumour-specific probes were designed from each clonal product by elimination of the consensus sequences. Ten digoxigenin-labelled probes were hybridized with a mixture of their res...Continue Reading
References
Jun 1, 1990·British Journal of Haematology·M J BriscoA A Morley
Jul 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·M YamadaG Rovera
Apr 1, 1968·Acta Haematologica·G L CastoldiW J Mitus
Apr 14, 1983·Nature·S Tonegawa
Jan 1, 1997·Leukemia·P J SykesA A Morley
May 1, 1997·British Journal of Haematology·R G OwenG J Morgan
Dec 9, 1998·Leukemia·M J Pongers-WillemseJ J van Dongen
Dec 16, 1998·Lancet·J J van DongenC R Bartram
Apr 8, 1999·Leukemia & Lymphoma·Z Estrov, M H Freedman
Jun 10, 2000·British Journal of Haematology·E KwanM Haber
Aug 15, 2000·Leukemia·M BrüggemannM Kneba
Aug 15, 2000·Leukemia·O J VerhagenC E van der Schoot
Oct 31, 2001·Leukemia Research·A H LiG Roos
Nov 6, 2001·Onkologie·M N Dworzak
Oct 18, 2002·Experimental Hematology·Ai-Hong LiGöran Roos
Jan 17, 2003·Leukemia·E BjörklundA Porwit-MacDonald
Feb 28, 2003·Hematological Oncology·E LealP Barros-Núñez